Annual Cash & Cash Equivalents
$20.07 B
-$571.00 M-2.77%
December 1, 2024
Summary
- As of February 24, 2025, MET annual cash & cash equivalents is $20.07 billion, with the most recent change of -$571.00 million (-2.77%) on December 1, 2024.
- During the last 3 years, MET annual cash & cash equivalents has risen by +$21.00 million (+0.10%).
- MET annual cash & cash equivalents is now -17.10% below its all-time high of $24.21 billion, reached on December 31, 2008.
Performance
MET Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$20.07 B
-$1.70 B-7.80%
December 1, 2024
Summary
- As of February 24, 2025, MET quarterly cash and cash equivalents is $20.07 billion, with the most recent change of -$1.70 billion (-7.80%) on December 1, 2024.
- Over the past year, MET quarterly cash and cash equivalents has stayed the same.
- MET quarterly cash and cash equivalents is now -19.85% below its all-time high of $25.04 billion, reached on June 30, 2021.
Performance
MET Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MET Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.8% | 0.0% |
| 3 y3 years | +0.1% | 0.0% |
| 5 y5 years | +20.9% | 0.0% |
MET Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.8% | +0.1% | -14.6% | +34.6% |
| 5 y | 5-year | -2.8% | +20.9% | -19.9% | +34.6% |
| alltime | all time | -17.1% | +182.4% | -19.9% | +1154.3% |
MetLife Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $20.07 B(-2.8%) | $20.07 B(-7.8%) |
| Sep 2024 | - | $21.77 B(+4.7%) |
| Jun 2024 | - | $20.79 B(+4.8%) |
| Mar 2024 | - | $19.84 B(-3.9%) |
| Dec 2023 | $20.64 B(+2.2%) | $20.64 B(+38.4%) |
| Sep 2023 | - | $14.91 B(-3.3%) |
| Jun 2023 | - | $15.42 B(-16.5%) |
| Mar 2023 | - | $18.46 B(-8.6%) |
| Dec 2022 | $20.20 B(+0.7%) | $20.20 B(-9.0%) |
| Sep 2022 | - | $22.20 B(+8.0%) |
| Jun 2022 | - | $20.55 B(-12.5%) |
| Mar 2022 | - | $23.49 B(+17.2%) |
| Dec 2021 | $20.05 B(+1.3%) | $20.05 B(+5.8%) |
| Sep 2021 | - | $18.96 B(-24.3%) |
| Jun 2021 | - | $25.04 B(+27.5%) |
| Mar 2021 | - | $19.64 B(-0.8%) |
| Dec 2020 | $19.80 B(+19.3%) | $19.80 B(-18.9%) |
| Sep 2020 | - | $24.41 B(+0.5%) |
| Jun 2020 | - | $24.29 B(+0.8%) |
| Mar 2020 | - | $24.09 B(+45.2%) |
| Dec 2019 | $16.60 B(+4.9%) | $16.60 B(-14.7%) |
| Sep 2019 | - | $19.45 B(+5.5%) |
| Jun 2019 | - | $18.43 B(+27.1%) |
| Mar 2019 | - | $14.51 B(-8.3%) |
| Dec 2018 | $15.82 B(+24.6%) | $15.82 B(+26.7%) |
| Sep 2018 | - | $12.49 B(-23.4%) |
| Jun 2018 | - | $16.31 B(+17.1%) |
| Mar 2018 | - | $13.93 B(+9.7%) |
| Dec 2017 | $12.70 B(+0.4%) | $12.70 B(-2.5%) |
| Sep 2017 | - | $13.02 B(-24.8%) |
| Jun 2017 | - | $17.32 B(-0.5%) |
| Mar 2017 | - | $17.41 B(+37.6%) |
| Dec 2016 | $12.65 B(-0.8%) | $12.65 B(-20.3%) |
| Sep 2016 | - | $15.88 B(-6.9%) |
| Jun 2016 | - | $17.07 B(+28.4%) |
| Mar 2016 | - | $13.29 B(+4.2%) |
| Dec 2015 | $12.75 B(+18.0%) | $12.75 B(+24.8%) |
| Sep 2015 | - | $10.22 B(+26.5%) |
| Jun 2015 | - | $8.07 B(-0.7%) |
| Mar 2015 | - | $8.13 B(-24.8%) |
| Dec 2014 | $10.81 B(+42.5%) | $10.81 B(+23.1%) |
| Sep 2014 | - | $8.78 B(+18.8%) |
| Jun 2014 | - | $7.39 B(-13.8%) |
| Mar 2014 | - | $8.57 B(+13.0%) |
| Dec 2013 | $7.58 B | $7.58 B(-33.3%) |
| Sep 2013 | - | $11.38 B(+23.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $9.18 B(-8.0%) |
| Mar 2013 | - | $9.98 B(-36.6%) |
| Dec 2012 | $15.74 B(+50.4%) | $15.74 B(-7.2%) |
| Sep 2012 | - | $16.95 B(+5.7%) |
| Jun 2012 | - | $16.04 B(-14.1%) |
| Mar 2012 | - | $18.67 B(+78.4%) |
| Dec 2011 | $10.46 B(-19.8%) | $10.46 B(+4.6%) |
| Sep 2011 | - | $10.00 B(+3.9%) |
| Jun 2011 | - | $9.63 B(-10.0%) |
| Mar 2011 | - | $10.69 B(-18.0%) |
| Dec 2010 | $13.05 B(+29.0%) | $13.05 B(+21.9%) |
| Jun 2010 | - | $10.70 B(+16.3%) |
| Mar 2010 | - | $9.20 B(-9.0%) |
| Dec 2009 | $10.11 B(-58.2%) | $10.11 B(-35.0%) |
| Sep 2009 | - | $15.56 B(+17.8%) |
| Jun 2009 | - | $13.21 B(-32.0%) |
| Mar 2009 | - | $19.42 B(-19.8%) |
| Dec 2008 | $24.21 B(+143.0%) | $24.21 B(+19.8%) |
| Sep 2008 | - | $20.21 B(+46.3%) |
| Jun 2008 | - | $13.81 B(+27.0%) |
| Mar 2008 | - | $10.87 B(+9.2%) |
| Dec 2007 | $9.96 B(+40.2%) | $9.96 B(+15.5%) |
| Sep 2007 | - | $8.63 B(+32.6%) |
| Jun 2007 | - | $6.50 B(-0.6%) |
| Mar 2007 | - | $6.54 B(-7.9%) |
| Dec 2006 | $7.11 B | $7.11 B(+20.0%) |
| Sep 2006 | - | $5.92 B(+43.6%) |
| Jun 2006 | - | $4.13 B(-19.8%) |
| Mar 2006 | - | $5.14 B(-26.0%) |
| Sep 2005 | - | $6.95 B(-48.9%) |
| Jun 2005 | - | $13.61 B(+246.7%) |
| Mar 2005 | - | $3.92 B(+9.3%) |
| Sep 2004 | - | $3.59 B(-19.4%) |
| Jun 2004 | - | $4.46 B(+41.7%) |
| Mar 2004 | - | $3.15 B(-41.4%) |
| Sep 2003 | - | $5.37 B(-6.0%) |
| Jun 2003 | - | $5.71 B(+15.7%) |
| Mar 2003 | - | $4.94 B(+35.4%) |
| Sep 2002 | - | $3.65 B(+2.4%) |
| Jun 2002 | - | $3.56 B(-11.5%) |
| Mar 2002 | - | $4.02 B(-9.5%) |
| Sep 2001 | - | $4.45 B(-6.4%) |
| Jun 2001 | - | $4.75 B(+12.9%) |
| Mar 2001 | - | $4.21 B(+162.8%) |
| Sep 2000 | - | $1.60 B(-49.8%) |
| Jun 2000 | - | $3.19 B(+42.5%) |
| Mar 2000 | - | $2.24 B |
FAQ
- What is MetLife annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MetLife?
- What is MetLife annual cash & cash equivalents year-on-year change?
- What is MetLife quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MetLife?
- What is MetLife quarterly cash and cash equivalents year-on-year change?
What is MetLife annual cash & cash equivalents?
The current annual cash & cash equivalents of MET is $20.07 B
What is the all time high annual cash & cash equivalents for MetLife?
MetLife all-time high annual cash & cash equivalents is $24.21 B
What is MetLife annual cash & cash equivalents year-on-year change?
Over the past year, MET annual cash & cash equivalents has changed by -$571.00 M (-2.77%)
What is MetLife quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MET is $20.07 B
What is the all time high quarterly cash and cash equivalents for MetLife?
MetLife all-time high quarterly cash and cash equivalents is $25.04 B
What is MetLife quarterly cash and cash equivalents year-on-year change?
Over the past year, MET quarterly cash and cash equivalents has changed by $0.00 (0.00%)